Research article · 15 Jul 2025
Mini reviewPublished 31 Dec 2022
Compound library design using data-driven approaches for parkinson's disease treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parkinson’s complaint (PD) is the alternate most common neurodegenerative complaint in aged individualities worldwide. Pharmacological treatment for such a complaint consists of medicines similar as monoamine oxidase B (MAO- B) impediments to increase dopamine attention in the brain. still, similar medicines have adverse responses that limit their use for extended ages; therefore, the design of lower poisonous and more effective composites may be explored. In this environment, cheminformatics and computational chemistry have lately contributed to developing new medicines and the hunt for new remedial targets. thus, through a data- driven approach, we used cheminformatic tools to find and optimize new composites with pharmacological exertion against MAO- B for treating PD. First, we recaptured from the literature 3316 original papers published between 2015 – 2021 that experimentally tested 215 natural composites against PD. From similar composites, we erected a pharmacological network that showed rosmarinic acid, chrysin, naringenin, and cordycepin as the most connected bumps of the network. From similar composites, we performed characteristic analysis and developed evolutionary libraries to gain new derived structures. We filtered these composites through a docking test against MAO- B and attained five deduced composites with advanced affinity and lead likeness eventuality. also we estimated its antioxidant and pharmacokinetic eventuality through a docking analysis (NADPH oxidase and CYP450) and physiologically- grounded pharmacokinetic (PBPK modeling). Interestingly, only one emulsion showed binary exertion (antioxidant and MAO- B impediments) and pharmacokinetic eventuality to be considered a possible seeker for PD treatment and farther experimental analysis.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in Journal of Neurology and Neuroscience.
Research article · 15 Jul 2025
Diffuse Intrinsic Pontine Glioma: Unusually Long Survival of 28 Patients (From 3 Years to Over 29 Years) in Phase 2 Studies with Antineoplastons A10 and AS2-1
Short communication · 24 Jun 2025
The Role of High-Pressure Balloon Angioplasty in Treating Intracranial Atherosclerosis
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology and Neuroscience
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Edgar Segura”
